- Home
- FBP vs GRFS Comparison
FBP vs GRFS Comparison
Compare FBP & GRFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FBP | GRFS |
|---|---|---|
| Founded | 1948 | 1940 |
| Country | United States | Spain |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.5B | 4.9B |
| IPO Year | 2010 | 2008 |
Fundamental Metrics
Financial Performance| Metric | FBP | GRFS |
|---|---|---|
| Price | $26.66 | $7.30 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 7 | 2 |
| Target Price | ★ $31.71 | $10.87 |
| AVG Volume (30 Days) | ★ 1.1M | 375.7K |
| Earning Date | 10-22-2026 | 07-28-2022 |
| Dividend Yield | ★ 3.04% | 1.17% |
| EPS Growth | ★ 18.78 | N/A |
| EPS | ★ 1.19 | N/A |
| Revenue | ★ $1,255,034,000.00 | N/A |
| Revenue This Year | $8.88 | $1.73 |
| Revenue Next Year | $4.40 | $6.26 |
| P/E Ratio | $22.18 | ★ $18.67 |
| Revenue Growth | ★ 2.38 | N/A |
| 52 Week Low | $19.16 | $6.96 |
| 52 Week High | $29.88 | $10.16 |
Technical Indicators
Market Signals| Indicator | FBP | GRFS |
|---|---|---|
| Relative Strength Index (RSI) | 29.35 | 41.48 |
| Support Level | $25.72 | $7.21 |
| Resistance Level | $26.94 | $8.41 |
| Average True Range (ATR) | 0.48 | 0.10 |
| MACD | -0.13 | -0.00 |
| Stochastic Oscillator | 0.00 | 36.67 |
Price Performance
Historical ComparisonAbout FBP First BanCorp. New
First BanCorp is a financial holding company. The company's operating segment includes Mortgage Banking; Consumer (Retail) Banking; Commercial and Corporate Banking; Treasury and Investments; United States Operations; and Virgin Islands Operations. The Consumer (Retail) Banking segment generates the majority of revenue, which consists of the Corporation's consumer lending and deposit-taking activities conducted mainly through its branch network and loan centres. Geographically, it derives a majority of revenue from Puerto Rico.
About GRFS Grifols S.A.
Grifols SA is a healthcare company engaged in activities related to plasma-derived products and diagnostic solutions. The group has four reportable segments: Biopharma, Diagnostic, Bio Supplies, and Others. The Biopharma segment focuses on products derived from human plasma for therapeutic use, while the Diagnostic segment includes the marketing of diagnostic testing equipment and reagents. The Bio Supplies segment covers biological products for non-therapeutic use and plasma sales to third parties, and the Others segment includes manufacturing services, research activities, and complementary pharmaceutical products.